{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:27:21Z","timestamp":1760171241096,"version":"3.44.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jim.2021.113086","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:43:55Z","timestamp":1623872635000},"page":"113086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterization and ex vivo expansion of rare in situ cytokine secreting T cell populations from tumor tissue and blood of oral squamous cell carcinoma patients"],"prefix":"10.1016","volume":"496","author":[{"given":"Slava","family":"Stamova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Ott-R\u00f6tzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Smetak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Sch\u00e4ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten E.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Beckhove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Spanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113086_bb0005","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27403","article-title":"Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer","volume":"3","author":"Balermpas","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jim.2021.113086_bb0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.6004\/jnccn.2012.0084","article-title":"Ten years of progress in head and neck cancers","volume":"10","author":"Baxi","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jim.2021.113086_bb0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","article-title":"Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells","volume":"195","author":"Becker","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI200420278","article-title":"Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors","volume":"114","author":"Beckhove","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113086_bb0025","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.4049\/jimmunol.1002549","article-title":"Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-beta blockade during the perioperative period of tumor resection","volume":"186","author":"Bellavance","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0030","first-page":"175","article-title":"Isolation and expansion of tumor-reactive cytotoxic T-cell clones for adoptive immunotherapy","volume":"109","author":"Bernhard","year":"2005","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0035","first-page":"3311","article-title":"Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma","volume":"119","author":"Bonertz","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113086_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2011.12","article-title":"FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes","volume":"1","author":"Brackertz","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jim.2021.113086_bb0045","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.1003961","article-title":"The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development","volume":"187","author":"Castro","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0050","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3389\/fimmu.2018.02826","article-title":"Transcriptional and epigenetic regulation of effector and memory CD8 T cell differentiation","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0055","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2004-01-0366","article-title":"Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma","volume":"105","author":"Choi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jim.2021.113086_bb0060","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2016.68.1478","article-title":"Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and\/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort","volume":"34","author":"Chow","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jim.2021.113086_bb0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","article-title":"IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors","volume":"121","author":"Cieri","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jim.2021.113086_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2021.113086_bb0075","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/annonc\/mdv239","article-title":"Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials","volume":"26","author":"Dieci","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jim.2021.113086_bb0080","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Disease","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2021.113086_bb0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J. Immunother."},{"key":"10.1016\/j.jim.2021.113086_bb0090","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jim.2021.113086_bb0095","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.18632\/oncotarget.6979","article-title":"Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer","volume":"7","author":"Feng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jim.2021.113086_bb0100","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0105","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jim.2021.113086_bb0110","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3322","article-title":"Paths to stemness: building the ultimate antitumour T cell","volume":"12","author":"Gattinoni","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jim.2021.113086_bb0120","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.1117194109","article-title":"Polyfunctional responses by human T cells result from sequential release of cytokines","volume":"109","author":"Han","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2021.113086_bb0125","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1073\/pnas.0501437102","article-title":"Memory T cells have gene expression patterns intermediate between naive and effector","volume":"102","author":"Holmes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2021.113086_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/CJI.0000000000000128","article-title":"The distribution of human stem cell-like memory T cell in lung cancer","volume":"39","author":"Hong","year":"2016","journal-title":"J. Immunother."},{"key":"10.1016\/j.jim.2021.113086_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/CJI.0b013e31824e801f","article-title":"Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment","volume":"35","author":"Jin","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.jim.2021.113086_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2021.113086_bb0145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.20020772","article-title":"Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells","volume":"196","author":"Judge","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0155","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","article-title":"Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo","volume":"32","author":"Kalia","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2021.113086_bb0165","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1084\/jem.20070543","article-title":"Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo","volume":"204","author":"Kamimura","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0170","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1158\/0008-5472.CAN-13-2564","article-title":"Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody","volume":"74","author":"Karyampudi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2021.113086_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jss.2014.06.001","article-title":"The prognostic value of liver tumor T cell infiltrates","volume":"191","author":"Khan","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.jim.2021.113086_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/onci.18851","article-title":"TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients","volume":"1","author":"Kvistborg","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jim.2021.113086_bb0185","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20030725","article-title":"IL-7 promotes the transition of CD4 effectors to persistent memory cells","volume":"198","author":"Li","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0190","first-page":"594","article-title":"Superior T memory stem cell persistence supports long-lived T cell memory","volume":"123","author":"Lugli","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113086_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nprot.2012.143","article-title":"Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells","volume":"8","author":"Lugli","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jim.2021.113086_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2567.2005.02163.x","article-title":"Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells","volume":"115","author":"Mahnke","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jim.2021.113086_bb0205","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","article-title":"The who\u2019s who of T-cell differentiation: human memory T-cell subsets","volume":"43","author":"Mahnke","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1172\/JCI200523134","article-title":"Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool","volume":"115","author":"Melchionda","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113086_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jim.2021.113086_bb0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11912-018-0654-5","article-title":"Immunotherapy for head and neck squamous cell carcinoma","volume":"20","author":"Moskovitz","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jim.2021.113086_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jim.2007.01.001","article-title":"Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens","volume":"320","author":"Neudorfer","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2021.113086_bb0230","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1245\/s10434-018-6658-4","article-title":"An update on immunotherapy for solid tumors: a review","volume":"25","author":"Pham","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jim.2021.113086_bb0235","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2021.113086_bb0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/imr.12644","article-title":"The role of cytokines in T-cell memory in health and disease","volume":"283","author":"Raeber","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jim.2021.113086_bb0245","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI74894","article-title":"Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis","volume":"125","author":"Reissfelder","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113086_bb0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/ol.2014.2103","article-title":"Histological and molecular aspects of oral squamous cell carcinoma (review)","volume":"8","author":"Rivera","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jim.2021.113086_bb0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jim.2021.113086_bb0265","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jim.2021.113086_bb0270","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.coi.2004.09.012","article-title":"Chemoattractants and their receptors in homeostasis and inflammation","volume":"16","author":"Sallusto","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0275","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jim.2021.113086_bb0280","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jim.2021.113086_bb0285","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20071641","article-title":"Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates","volume":"205","author":"Sarkar","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2012.09.020","article-title":"Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets","volume":"38","author":"Sathaliyawala","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2021.113086_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/GCO.0000000000000433","article-title":"Cell-based immunotherapy in gynecologic malignancies","volume":"30","author":"Schaar","year":"2018","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.jim.2021.113086_bb0300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0305","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1158\/0008-5472.CAN-05-1098","article-title":"High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients","volume":"65","author":"Schmitz-Winnenthal","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2021.113086_bb0310","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4049\/jimmunol.175.3.1433","article-title":"Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells","volume":"175","author":"Schwendemann","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0315","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ni946","article-title":"Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells","volume":"4","author":"Seddon","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2021.113086_bb0320","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jim.2021.113086_bb0325","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1158\/0008-5472.CAN-05-2363","article-title":"Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes","volume":"66","author":"Sommerfeldt","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2021.113086_bb0330","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1158\/0008-5472.CAN-05-4201","article-title":"The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients","volume":"66","author":"Sommerfeldt","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2021.113086_bb0335","first-page":"31","article-title":"Consider the chemokines: a review of the interplay between chemokines and T cell subset function","volume":"24","author":"Strazza","year":"2017","journal-title":"Discov. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/odi.12884","article-title":"Enhanced chimeric antigen receptor T-cell therapy: a novel approach for head and neck cancers","volume":"25","author":"Wang","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.jim.2021.113086_bb0345","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.194.7.953","article-title":"Migratory properties of naive, effector, and memory CD8(+) T cells","volume":"194","author":"Weninger","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00384-018-3202-8","article-title":"Current status of immunotherapy in metastatic colorectal cancer","volume":"34","author":"Wrobel","year":"2019","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.jim.2021.113086_bb0355","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","article-title":"CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro","volume":"185","author":"Wu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2021.113086_bb0360","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:40:23Z","timestamp":1758300023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":72,"alternative-id":["S0022175921001319"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113086","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and ex vivo expansion of rare in situ cytokine secreting T cell populations from tumor tissue and blood of oral squamous cell carcinoma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113086"}}